Skip to main content

Table 1 Demographics and clinical characteristics of FEDN patients with schizophrenia and healthy controls

From: Increased serum homocysteine in first episode and drug-naïve individuals with schizophrenia: sex differences and correlations with clinical symptoms

 

FEDN (n = 119)

HC (n = 81)

F/χ2

P

Age (years)a

27.73 ± 7.54

25.95 ± 6.56

2.979

0.086

Sex (M/F)

60/59

42/39

0.040

0.842

Education (years)a

12.23 ± 2.00

12.57 ± 2.31

1.235

0.268

Smoking (Yes/No)

25/94

13/68

0.770

0.380

BMI (kg/m2)a

24.62 ± 2.96

24.30 ± 2.39

0.609

0.436

Duration of untreated illness (years)a

1.99 ± 1.83

   

Age at onset (years)a

25.75 ± 6.56

   

PANSS positive subscorea

27.91 ± 7.33

   

PANSS negative subscorea

16.09 ± 7.58

   

PANSS general subscorea

25.18 ± 9.29

   

PANSS total scorea

69.18 ± 14.81

   

Hcy (μmol/L)b

19.80 (15.51, 16.40)

13.01 (11.65, 16.55)

46.865

 < 0.001

  1. FEDN first-episode drug-naïve, HC healthy control, BMI body mass index, PANSS Positive and Negative Syndrome Scale, Hcy homocysteine
  2. aThe data were expressed as the mean ± standard deviation
  3. bThe data were expressed as the median (25th quartile and 75th quartile). Significant difference (P < 0.05) is indicated in bold